NCT06568133View on ClinicalTrials.gov

Drug-drug Interaction Study Between UIC201603, and UIC201604

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

July 4, 2017

Study Completion Date

February 7, 2018

Conditions

Healthy

Interventions

DRUG

UIC201603 and co-administration of UIC201603 and UIC201604

"* UIC201603 2 Caps/day for 7 days~* Wash out 7 days~* UIC201603 2 Caps/day + UIC201604 1 Tabs/day for 7 days"

DRUG

UIC201604 and co-administration of UIC201603 and UIC201604

"* UIC201604 1 Tabs/day for 7 days~* Wash out 7 days~* UIC201603 2 Caps/day + UIC201604 1 Tabs/day for 7 daysadministration of UIC201603 and UIC201604"

Trial Locations (1)

Unknown

Chungnam National University Hospital, Daejeon

All Listed Sponsors

lead

Korea United Pharm. Inc.

INDUSTRY

NCT06568133 - Drug-drug Interaction Study Between UIC201603, and UIC201604 | Biotech Hunter | Biotech Hunter